1. Preclinical validation of ERK inhibition via GDC-0994 as a potent therapeutic strategy in BRAFV600E mutant colorectal cancers. (December 2016) Authors: Schaefer, G.; Chan, J.; Shao, L.; Kirouac, D.; Orr, C.; Hunsaker, T.; De la Cruz, C.; Merchant, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository. (1st October 2021) Authors: Lecaros, C.; Dunstan, J.; Villena, F.; Ashcroft, D. M.; Parisi, R.; Griffiths, C. E. M.; Härtel, S.; Maul, J. T.; De la Cruz, C. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository. (26th June 2021) Authors: Lecaros, C.; Dunstan, J.; Villena, F.; Ashcroft, D. M.; Parisi, R.; Griffiths, C. E. M.; Härtel, S.; Maul, J. T.; De la Cruz, C. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗